We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Ring with Lab-on-a-Chip Technology Rapidly Diagnoses STDs in a Single Blood Test

By LabMedica International staff writers
Posted on 07 Sep 2015
Print article
Image: A highly portable personal diagnostic device has been developed in the form of a ring, the “Hoope,” worn on the thumb during testing. Initially the ring will enable rapid early detection of the sexually transmitted diseases (STDs) syphilis, gonorrhea, chlamydia, and trichomoniasis (Photo courtesy of Hoope).
Image: A highly portable personal diagnostic device has been developed in the form of a ring, the “Hoope,” worn on the thumb during testing. Initially the ring will enable rapid early detection of the sexually transmitted diseases (STDs) syphilis, gonorrhea, chlamydia, and trichomoniasis (Photo courtesy of Hoope).
A low-cost, point-of-care and personal diagnostics thumb-ring has been successfully developed to test for sexually transmitted diseases (STDs) such as syphilis, gonorrhea, chlamydia, and trichomoniasis, transmitting data to a smartphone where an app quickly presents the results.

The innovative “Hoope” ring was designed by mechanical engineer Ernesto Rodriguez Leal, PhD, from Monterrey (Mexico). "Every year more than 500 million people around the world contract one of these four STDs, 50% are between 15 to 23 years of age. The problem is that 75% do not present early symptoms, therefore the need for an early-detection strategy," he said.

Hoope is placed on the thumb and contains a disposable cartridge with a retractable single-use needle. It also contains an anesthetic system by which an electrical pulse generates numbness, preventing pain at the time of puncture. It is worn only at the time of testing and functions as a personal diagnostic tool. A button is pressed, activating the needle to draw blood, which is transported by capillary action and taken into a lab-on-a-chip, where the blood is distributed into 4 microfluidic channels. "We put antigens specifically synthesized to catch antibodies for each of the diseases,” said Dr. Rodreges Leal, “If antibodies for any of the conditions exists, the antigens trap them and produce an electrochemical reaction."

Data are wirelessly transmitted to a device such as a smartphone or tablet, where an app shows the results in less than a minute. In cases of positive results, the app provides related medical information and a map showing the location of the nearest specialist with whom an appointment can be scheduled.

The Hoope portable device project was developed at a Mexican startup in Silicon Valley. "There I met Damel Mektepbayeva, biotechnologist from Kazakhstan, and Irina Rymshina, Russian finance expert, the three of us decided to create Hoope," explained Dr. Rodríguez Leal. He arrived to Silicon Valley through the Singularity University program consisting of a 3-month stay at NASA that brings together 80 people from around the world. "In this program I learned the tools needed to conceptualize social impact projects and transform the idea from the lab to an end product," he said, "The first prototype was designed at the Colorado State University located in Fort Collins, it showed excellent results in the detection of syphilis, and we are working to perfect it for the other three diseases."

With this technological development the researchers have won several international competitions. The device will be manufactured in China and made available January 2016 through an Indiegogo campaign. A specialized app will also be released. Hoope will initially be marketed in Latin America (later in Europe and the United States) at a price of approximately USD 50 for the ring and three cartridges. Currently the team continues to improve the device, including for its potential to be adapted to detect allergies, cancer, diabetes, and pregnancy.

Related Links:

Hoope
Singularity University 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The real-time multiplex PCR test is set to revolutionize early sepsis detection (Photo courtesy of Shutterstock)

1 Hour, Direct-From-Blood Multiplex PCR Test Identifies 95% of Sepsis-Causing Pathogens

Sepsis contributes to one in every three hospital deaths in the US, and globally, septic shock carries a mortality rate of 30-40%. Diagnosing sepsis early is challenging due to its non-specific symptoms... Read more

Pathology

view channel
Image: The QIAseq xHYB Mycobacterium tuberculosis Panel uses next-generation sequencing (Photo courtesy of 123RF)

New Mycobacterium Tuberculosis Panel to Support Real-Time Surveillance and Combat Antimicrobial Resistance

Tuberculosis (TB), the leading cause of death from an infectious disease globally, is a contagious bacterial infection that primarily spreads through the coughing of patients with active pulmonary TB.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.